Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-04-24
DOI
10.1093/eurheartj/ehz299
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Different Causes of Death in Patients with Myocardial Infarction Type 1, Type 2, and Myocardial Injury
- (2018) Sascha Lambrecht et al. AMERICAN JOURNAL OF MEDICINE
- Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome
- (2018) Otavio Berwanger et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Fourth universal definition of myocardial infarction (2018)
- (2018) Kristian Thygesen et al. EUROPEAN HEART JOURNAL
- Alirocumab Reduces Fatal and Nonfatal Cardiovascular Events
- (2018) Michael Szarek et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discrimination of patients with type 2 myocardial infarction
- (2017) Johannes Tobias Neumann et al. EUROPEAN HEART JOURNAL
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury
- (2017) Andrew R. Chapman et al. CIRCULATION
- Myocardial Infarction Type 2 and Myocardial Injury
- (2016) Yader Sandoval et al. CLINICAL CHEMISTRY
- Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury
- (2016) German Cediel et al. HEART
- Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients
- (2016) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sensitive Troponin Assay and the Classification of Myocardial Infarction
- (2015) Anoop S.V. Shah et al. AMERICAN JOURNAL OF MEDICINE
- Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial
- (2014) Gregory G. Schwartz et al. AMERICAN HEART JOURNAL
- Mortality Rate in Type 2 Myocardial Infarction: Observations from an Unselected Hospital Cohort
- (2014) Lotte Saaby et al. AMERICAN JOURNAL OF MEDICINE
- Type 2 myocardial infarction in clinical practice
- (2014) Tomasz Baron et al. HEART
- Classification of Myocardial Infarction: Frequency and Features of Type 2 Myocardial Infarction
- (2013) Lotte Saaby et al. AMERICAN JOURNAL OF MEDICINE
- Third universal definition of myocardial infarction
- (2012) Kristian Thygesen et al. EUROPEAN HEART JOURNAL
- Angiographic Correlates in Type 1 and 2 MI by the Universal Definition
- (2012) John A. Ambrose et al. JACC-Cardiovascular Imaging
- Clinical Benefit of Statin Pretreatment in Patients Undergoing Percutaneous Coronary Intervention
- (2011) Giuseppe Patti et al. CIRCULATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now